— Know what they know.
Not Investment Advice
Why is ADMA crashing?
A
Why is ADMA crashing?
πŸ¦‰

ADMA is up N/A at $8.24

Catalysts

Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
Will the IG Market Challenges Affect ADMA Biologics Prospects in 2026?

Performance

5 Day-0.47%
1 Month-22.74%
3 Month-47.45%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms